If you must take these medications together, close monitoring by a healthcare provider is essential to adjust dosages accordingly
Research has shown that, in addition to improving glycaemic control and weight loss, GLP-1RAs can impact other risk factors for cardiovascular (CV) complications, including lowering systolic blood pressure and modifying plasma lipids and markers of inflammation [18]
Many people notice: Smaller portions feel satisfying Fewer cravings between meals Less urge to snack out of habit or boredom This is a sign that hunger signals are becoming more regulated, not eliminated
Yes, switching from an injection (like Wegovy or Zepbound) to the oral pill is possible and is a common option for patients experiencing needle fatigue or injection site reactions
Other weight loss medications work in different ways or may not be as strong as semaglutide or tirzepatide
Not enough to matter clinically